Source:http://linkedlifedata.com/resource/pubmed/id/16806591
General Info
Affiliation
Service de médecine gériatrique, centre hospitalo-universitaire Bichat-Claude-Bernard, 48, rue Henri-Huchard, 75877 Paris, France.Abstract
Cholinesterase Inhibitors (ChEIs) have proven efficacy in outpatients with mild to moderate Alzheimer's Disease (AD). The benefits of maintaining this treatment once patients are institutionalised remain controversial. The aim of this study was to present current therapeutic strategies regarding ChEIs use in long-term care settings (LTC).
PMID
16806591
Publication types
English Abstract; Multicenter Study